Dr. Cinciripini is a tenured professor and Margaret and Ben Love Chair in Clinical Cancer Care in honor of Dr. Charles A. LeMaistre at The University of Texas MD Anderson Cancer Center. He serves as chair for the Department of Behavioral Science and is the director of the Tobacco Treatment Program. His major research interests include studies developing novel behavioral and pharmacological treatments for nicotine dependence and those that study individual differences associated with treatment outcome. His work in this area has focused on psychological (negative affect, coping self-efficacy), psychophysiological (emotional reactivity), neural (EEG/fMRI), and genetic predictors of treatment outcome (pharmacogenetics). He has conducted over 21 NIH and other sponsored randomized clinical trials examining behavioral and pharmacological interventions for smoking cessation.